Federal award (PURCHASE ORDER, fiscal year 2024)
Recipient: PEARSON PHARMA PARTNERS
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2022-07-01 to 2025-06-30
Current total value of award: $330000
Description: DRUG METABOLISM PHARMACOKINETICS (DMPK) CONSULTING SUPPORT SERVICES